Evidence map›Paper›PMID 42303659›Full record

ArticleScientific reports2026

Correction: Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer.

Hsiao-Ling Chen, Chen-Han Chueh, Wei-Ming Huang, Shu-Hua Chan, Hsiao-Hsiang Cheng, Shao-Chin Chiang, Chiao-En Wu, Yu-Wen Wen, Yi-Wen Tsai

Abstract readPublished Erratum
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Hsiao-Ling ChenInstitute of Health and Welfare Policy, National Yang Ming Chiao Tung University, No. 155, Sec.2, Linong Street, Taipei City, Taiwan.
Chen-Han ChuehHerbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, San Diego, CA, USA.
Wei-Ming HuangInstitute of Health and Welfare Policy, National Yang Ming Chiao Tung University, No. 155, Sec.2, Linong Street, Taipei City, Taiwan.
Shu-Hua ChanDepartment of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Hsiao-Hsiang ChengDepartment of Oncology and Hematology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.
Shao-Chin ChiangDepartment of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chiao-En WuDivision of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Yu-Wen Wen *Department of Biomedical Sciences, Chang Gung University, No.259, Wenhua 1St Rd., Guishan Dist, Taoyuan City, Taiwan. ywwen@mail.cgu.edu.tw.
Yi-Wen Tsai *Institute of Health and Welfare Policy, National Yang Ming Chiao Tung University, No. 155, Sec.2, Linong Street, Taipei City, Taiwan. ywtsai@nycu.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42303659
PMCPMC13272893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.